United States · FDA National Drug Code directory
BIVIGAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69800-6502_3469d327-8d5d-fff5-e063-6394a90a2cf2
- Product NDC
- 69800-6502
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Immune Globulin Intravenous (Human) 10%
- Labeler
- ADMA Biologics, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20130121
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN IMMUNOGLOBULIN G — 5 g/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (69800-6502-1) / 50 mL in 1 VIAL, SINGLE-USE (69800-6502-2) · 69800-6502-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →